Predictive biomarkers for immunotherapy response in renal cell carcinoma: why have they failed?
{{output}}
Purpose of review: The heterogeneity of response to immunotherapies in renal cell carcinoma has created a strong need for predictive biomarkers to guide treatment decisions. However, no robust predictive biomarker has been adopte... ...
